CCR5 and infection: SIVmacC8 is ostensibly T-cell tropic, targeting CCR5+/CD4+ lymphocytes early in the infection process (Cantó-Nogués et al., 2001; Ferguson et al., 2014) and multiple lymphoid tissues resulting in the establishment of persistent virus infection in a highly dynamic process.